1. Home
  2. TOMZ vs CTXR Comparison

TOMZ vs CTXR Comparison

Compare TOMZ & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TOMZ

TOMI Environmental Solutions Inc.

HOLD

Current Price

$0.80

Market Cap

17.5M

Sector

Finance

ML Signal

HOLD

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$1.42

Market Cap

19.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOMZ
CTXR
Founded
1979
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.5M
19.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TOMZ
CTXR
Price
$0.80
$1.42
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$3.50
$6.00
AVG Volume (30 Days)
22.5K
576.4K
Earning Date
11-14-2025
12-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,688,341.00
N/A
Revenue This Year
$18.31
N/A
Revenue Next Year
$103.30
$731.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.65
52 Week High
$1.50
$5.95

Technical Indicators

Market Signals
Indicator
TOMZ
CTXR
Relative Strength Index (RSI) 40.84 58.45
Support Level $0.76 $0.97
Resistance Level $0.85 $1.54
Average True Range (ATR) 0.05 0.13
MACD 0.00 0.04
Stochastic Oscillator 43.48 81.49

Price Performance

Historical Comparison
TOMZ
CTXR

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: